Argatroban Impurities refer to any unwanted substances that may be present in the medication Argatroban. These impurities may occur during the manufacturing process or may be introduced during storage or handling. The presence of impurities can affect the purity and potency of the medication and may pose a risk to patient health. Therefore, it is important to monitor and control impurities in Argatroban to ensure its safety and efficacy.
Argatroban impurities are unwanted substances that can be present in argatroban drug products. These impurities can affect the purity, safety, and efficacy of the drug. It is important to monitor and control the levels of impurities in argatroban products to ensure their quality and safety for use in medical treatment. Various analytical techniques are used to detect and quantify argatroban impurities.
Other Reference Standards of Argatroban
| PRODUCT |
CAT NO. |
CATEGORY |
|
[13C6]-Argatroban
|
CS-EK-01686
|
Stable Isotopes
|
|
1,2,3,4-Tetrahydro Argatroban-d8
|
CS-T-97149
|
Stable Isotopes
|
|
Argatroban D3
|
CS-CX-00130
|
Stable Isotopes
|
|
N-Nitro-1,2,3,4-tetradehydro Argatroban-d8
|
CS-T-97260
|
Stable Isotopes
|
|
Argatroban
|
CS-T-04129
|
API Standards
|
|
"N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester"
|
CS-O-31618
|
Intermediates
|
|
"N-Nitro-1,2,3,4-tetradehydro Argatroban"
|
CS-O-30838
|
Intermediates
|
|
1,2,3,4-Tetradehydro Argatroban
|
CS-T-86230
|
Intermediates
|
|
21R-Argatroban
|
CS-T-04127
|
Intermediates
|
|
21S-Argatroban
|
CS-T-04128
|
Intermediates
|
|
Argatroban Intermediate
|
CS-T-95868
|
Intermediates
|
|
Argatroban monohydrate
|
CS-CX-00129
|
Intermediates
|
|
Argatroban Related Compound A(Secondary Standards traceble to USP)
|
CS-ER-00159
|
Secondary Standards
|
|
Argatroban Related Compound B (F0M536)
|
CS-EB-00172
|
USP Standards
|
|
Argatroban Related Compound B(Secondary Standards traceble to USP)
|
CS-ER-00160
|
Secondary Standards
|
|
Argatroban Related Compound C(Secondary Standards traceble to USP)
|
CS-ER-00165
|
Secondary Standards
|
